The FDA accepts Aldeyra's resubmitted NDA for topical ocular reproxalap to treat the signs and symptoms of dry eye disease.

On Monday, Aldeyra Therapeutics Inc (ALDX) stock saw a modest uptick, ending the day at $4.7 which represents a slight increase of $0.49 or 11.64% from the prior close of $4.21. The stock opened at $4 ...

The attack came just days after President Biden gave Ukraine permission to use the weapons to strike targets inside Russia. By Marc Santora and Eric Schmitt The envoy, Amos Hochstein, said an ...

Weakness in AmericaFirst Monthly Risk-On Risk-Off U's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative. Our research team assigns Negative ...

After hours: November 8 at 6:36 PM EST Loading Chart for CRDF ...

Stewart-Haas' sad demise belies its legacy of unlikely success (October 31, 2024, 7:00 PM ET) ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...

Get dialed in every Tuesday & Friday with quick updates on the world of crypto ...